Cardiologs Holter Platform

Philips France Commercial · K250569 · 2025-08-06

Cardiologs Holter Platform is an AI-enabled medical device from Philips France Commercial, listed by FDA (510(k), K250569) with a decision date of 2025-08-06. Review panel: Cardiovascular.

FDA submission numberK250569
Pathway510(k)
CompanyPhilips France Commercial
Review panel (specialty)Cardiovascular
FDA decision date2025-08-06
DecisionSubstantially Equivalent
Product codeDPS
ClassificationElectrocardiograph
Device class2
Regulation number870.2340
Review time (calendar days)161
Applicant countryFR

Official FDA database record · FDA AI-enabled device list

All Cardiovascular AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.